Diroximel
ATC — · 6 markets · 8 records
AU 3 records · 2 strengths
- 231 mgcapsule · delayed-releaseVumerityVUMERITY diroximel fumarate 231 mg enteric capsules bottle
Records without a stated strength · 1 Vumerity
US 1 records · 1 strengths
- 231 mgcapsuleVumerity
GB 1 records · 1 strengths
- 231 mgcapsule · delayed-releaseVumerity 231mg gastro-resistant capsules
ES 1 records · 1 strengths
- 231 mgcapsule · delayed-releaseVumerity
MX 1 records · 1 strengths
Records without a stated strength · 1 Vumerity
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Vumerity
| Strength / form / release | US | GB | AU | ES | MX | EU |
|---|---|---|---|---|---|---|
| 231 mg capsule · delayed-release | Vumerity 231mg gastro-resistant capsules | Vumerity VUMERITY diroximel fumarate 231 mg enteric capsules bottle | Vumerity | |||
| 231 mg capsule | Vumerity | |||||
unknown | Vumerity | Vumerity | ||||
capsule | Vumerity |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.